Carrell-Krusen Neuromuscular Symposium (CK 2026)

Dallas, TX
|
February 19 - 20, 2026
Focus: 
Myasthenia Gravis (MG)
Location: 
N/A

Publication Presented

Global Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis (RemeMG)